Hillsdale Investment Management Inc. Axonics, Inc. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$48.64 - $62.51 $972 - $1,250	20 Added 40.0%	70 $3,000
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $554,284 - $695,425	-11,550 Reduced 99.57%	50 $2,000
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $59,560 - $76,600	1,000 Added 9.43%	11,600 $725,000
Q3 2022 Nov 10, 2022	BUY	$57.96 - $78.12 $614,376 - $828,072	10,600 New	10,600 $747,000

235

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.